~~<i id='1482BA9121'><strike id='1482BA9121'><tt id='1482BA9121'><pre id='1482BA9121'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：hotspot 2025-09-30 20:18:25 - browse：5

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.

Trading in Sarepta shares was halted at $107 with the release of the study results.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Wikipedia

hotspot

focus

hotspot

Wikipedia

leisure time

FILE-RepublicofIreland'sSineadFarrelly,center,greetsplayersaftertheteam'smatchwiththeUnitedStatesina

WSS

After half a century, Israel moves to evict squatter from his cave home on the beach

One Duchenne patient's bittersweet hope for new treatment

Women's World Cup brings attention to abuse in soccer

Chemotherapy shortages won’t get better under Biden’s latest plan

Companies helping big Covid

One Duchenne patient's bittersweet hope for new treatment

explore

fashion

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

Radiology is caught between AI's potential and concern for patients

Trump demands the U.S. pay no more for drugs than other countries … again

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Superbugs, antibiotic resistance get scrutiny in congress

Sports medicine is finally prioritizing gender equality

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Sports medicine is finally prioritizing gender equality

AI models in health care face new federal disclosure requirements

hotspot

Inflation cooled significantly in June, bringing price hikes close to normal levels

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

In diabetes hearing, Sanders takes on a new foe: food makers

Roche to buy Carmot Therapeutics, developer of obesity drugs

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

focus

hotspot

Wikipedia

leisure time